Article ; Online: Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients.
2021 Volume 28, Issue 6, Page(s) 394–400
Abstract: ... in hematopoietic cell transplant and chimeric antigen receptor T-cell therapy recipients over the past year and ... Purpose of review: To discuss the clinical experience of coronavirus disease 2019 (COVID-19 ... characteristics and outcomes of transplant and cellular therapy (TCT) recipients who developed COVID-19. Age, sex ...
| Abstract | Purpose of review: To discuss the clinical experience of coronavirus disease 2019 (COVID-19) in hematopoietic cell transplant and chimeric antigen receptor T-cell therapy recipients over the past year and to identify key knowledge gaps for future research. Recent findings: Immunocompromised individuals and those with chronic health conditions are especially susceptible to infections, which have had a disproportionate impact on health outcomes during the COVID-19 pandemic. Several studies have evaluated the clinical characteristics and outcomes of transplant and cellular therapy (TCT) recipients who developed COVID-19. Age, sex, comorbid conditions, and social determinants of health are important predictors of the risk of severe acute respiratory syndrome coronavirus 2 infection and of the eventual severity of the disease. Various treatment approaches have been investigated over the last year. The paradigm of management strategies continues to evolve as more experience is accumulated. Summary: In this review, we summarize some important findings as they relate to the clinical characteristics of TCT recipients who develop COVID-19. We also discuss some treatment approaches that are currently recommended and opine on vaccination in this population. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; Cell- and Tissue-Based Therapy/standards ; Hematopoietic Stem Cell Transplantation/standards ; Humans ; Immunocompromised Host ; Practice Guidelines as Topic/standards ; Receptors, Chimeric Antigen/immunology ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; Transplant Recipients/statistics & numerical data | |||||
| Chemical Substances | Receptors, Chimeric Antigen | |||||
| Language | English | |||||
| Publishing date | 2021-07-27 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review | |||||
| ZDB-ID | 1153887-9 | |||||
| ISSN | 1531-7048 ; 1065-6251 | |||||
| ISSN (online) | 1531-7048 | |||||
| ISSN | 1065-6251 | |||||
| DOI | 10.1097/MOH.0000000000000683 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3703: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.